News/ News/ R&D Celleron targets Daiichi Sankyo with Roche’s unwanted rare cancer drug Richard Staines Celleron, R&D, Roche, tenosynovial giant cell tumour 0 Comment UK biotech Celleron Therapeutics has bought a licence to develop, manufacture and market emactuzumab, an unwanted drug from Share X Celleron targets Daiichi Sankyo with Roche’s unwanted rare cancer drug https://pharmaphorum.com/news/celleron-targets-daiichi-sankyo-with-roches-unwanted-rare-cancer-drug/
Celleron, R&D, Roche, tenosynovial giant cell tumour
0 Comment
